There has been quite a stir this week with the publication of the newest revision of the ACC/AHA guidelines for the treatment of cholesterol. The New York Times is awash with articles summarizing or opining on the changes and many of the authors are perspicacious observers:- 3 Things to Know About the New Cholesterol Guidelines by Harlan Krumholz of Yale
- Don’t Give More Patients Statins by authors from Harvard and UCSF
- Experts Reshape Treatment Guide for Cholesterol
- New Cholesterol Advice Startles Even Some Doctors
- Questions For A New Class of Cholesterol Drugs
As the old Spanish proverb states, "rio revuelto, ganancia de pescadores" - when the river is stirred up, the fishermen benefit. I will admit that I'm gloating a bit since I consider the new guidelines to be a tacit affirmative nod to several posts on the topic of the cholesterol hypothesis (CH). (More posts here and here and here, among several others - search for "cholesterol" or "causal pathways" on the Medical Evidence Blog search bar.)
